Enliven Therapeutics shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $810k | 53k | 15.40 |
| 2024-03-31 | $220k | 13k | 17.59 |
| 2023-06-30 | $27k | 34k | 0.80 |
| 2023-03-31 | $40k | 34k | 1.17 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management